Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates - Is postnatal age at start of treatment important?

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 19, Issue 12, 2006, Pages 797-801

  Srinivasjois, R M ^a   Nathan, E A ^a   Doherty, D A ^a,b   Patole, S K ^a,b,c  

^a KEM Hospital for Women   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

Creatinine; Indomethacin; Neonate; Postnatal age; Preterm; Renal impairment

Indexed keywords

INDOMETACIN;

ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GESTATIONAL AGE; HUMAN; HYPOVOLEMIA; KIDNEY DYSFUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; SODIUM BLOOD LEVEL; TREATMENT OUTCOME;

EID: 33845960952     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050600922610     Document Type: Article

References (26)

1. Bancalari E, Claure N, Gonzalez A. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 2005;88:192-201.
2. Noerr B. Current controversies in the understanding of necrotizing enterocolitis. Part 1. Adv Neonatal care 2003;3:107-120.
3. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001;6:63-73.
4. Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med 2000;343:728-730.
5. Fanaroff AA, Hack M, Walsh MC. The NICHD neonatal research network: Changes in practice and outcomes during the first 15 years. Semin Perinatol 2003;27:281-287.
6. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and low birth weight infants. Cochrane Database Syst Rev 2005;CD003481.
7. Christmann V, Leim KD, Semmekrot BA, Van de Bor M. Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. Acta Paediatr 2002;91:369-370.
8. Leonhardt A, Strehl R, Barth H, Seyberth HW. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus. Acta Paediatr 2004;93:233-240.
9. Kalia YN, Nonato LB, Luind CH, Guy RH. Development of skin barrier function in premature infants. J Invest Dermatol 1998;111:320-326.
10. Greeley C, Snell J, Colaco A, Beatley J, Bailey J, Bjorn SI. Pediatric reference ranges for electrolytes and creatinine. Clinical Chemistry 1993;39:1172.
11. Skinner J. Diagnosis of patent ductus arteriosus. Semin Neonatol 2001;6:49-61.
12. Skinner J, Alverson D, Hunter S. Echocardiography for the neonatologist. 1st ed. London: Churchill Livingstone; 2000.
13. Rutter N. Clinical consequences of an immature barrier. Semin Neonatol 2000;5:281-287.
14. Agren J, Sjors G, Sedin G. Transepidermal water loss in infants born at 24 weeks of gestation. Acta Paediatr 1998;87:1185-1190.
15. Fanaroff AA, Wald M, Gruber HS, Klaus MH. Insensible water loss in low birth weight infants. Pediatrics 1972;50:236-245.
16. Baumgart S, Engle WD, Fox WW, Polin RA. Radiant warmer power and body size as determinants of insensible water loss in the critically ill neonate. Pediatr Res 1981;15:1495-1499.
17. Rutter N. The hazards of an immature skin. In: Harvey D, Cooke RWI, Levitt GA, editors. Practical perinatal care - the baby under 1000 grams. London: Butterworth and Co.; 1989. p 99.
18. Lorenz JM, Kleinman LI, Kotagal UR, Reller MD. Water balance in very low birth weight infants: Relationship to water and sodium intake and effect on outcome. J Pediatr 1982;101:423-432.
19. Dimitriou G, Kavvadia V, Marcow M, Greengough A. Antenatal steroids and fluid balance in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2005;90:F509-513.
20. Zanardo V, Vedovato S, Lago P, Piva D, Faggian D, Chiozza L. Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus. Fetal Diagn Ther 2005;20:534-539.
21. Aranda JV, Yaffe SJ. Neonatal and pediatric pharmacology. Therapeutic principles in practice. 3rd ed. London: Lippincott Williams and Wilkins; 2004. pp 672-676.
22. Walker MP, Moore TR, Brace RA. Indomethacin and arginine-vasopressin interaction in the fetal kidney: A mechanism of oliguria. Am J Obstet Gynecol 1994;171:1234-1241.
23. Maston JR, Stokes JB, Robillard JE. Effects of inhibition of prostaglandin-synthesis on fetal renal function. Kidney Int 1981;20:621-627.
24. Cotton RB. Don't discard your indomethacin yet. Acta Pediatr 2000;89:1279.
25. Roberts LJ, Morrow JD. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbard LE, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p 695.
26. Chamama NS, Mosig D, Drukker A, Guingnard JP. The renal hemodynamic effects of ibuprofen in the newborn rabbit. Pediatr Res 2000;48:600-605.